AI Article Synopsis

  • The study examines how the drug dapagliflozin impacts changes in pulmonary blood vessels in rats exposed to chronic low oxygen levels.
  • Eighteen female rats were divided into three groups: one exposed to normal oxygen, one to low oxygen, and one to low oxygen plus dapagliflozin treatment.
  • Results showed that dapagliflozin reduced artery wall thickness and heart enlargement caused by low oxygen, suggesting it may help counteract harmful changes in lung and heart tissues.

Article Abstract

Objective: To investigate the effects of sodium-glucose co-transporter 2 inhibitor dapagliflozin on pulmonary vascular remodeling in a rat model of chronic hypoxic pulmonary arterial hypertension.

Methods: Eighteen female Sprague-Dawley rats were divided into three groups: control (CON), chronic hypoxia (HYP), and chronic hypoxia + dapagliflozin. The HYP and dapagliflozin groups were subjected to hypoxia and received saline or dapagliflozin. The CON group was normoxic and received saline. Body weight and fasting blood glucose were measured, and after 21 days, lung and heart tissues were analyzed for pulmonary artery reconstruction and right ventricular hypertrophy. Western blotting assessed Bax and Bcl-2 protein levels.

Results: Chronic hypoxia increased pulmonary artery wall thickness and lung fibrosis and caused right ventricular hypertrophy. Dapagliflozin reduced these changes, decreasing artery wall thickness, fibrosis, and hypertrophy while increasing the Bax/Bcl-2 ratio.

Conclusion: Dapagliflozin alleviates chronic hypoxia-induced pulmonary artery wall thickening and lung tissue fibrosis in rats, potentially through proapoptotic effects.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10799893.2024.2433083DOI Listing

Publication Analysis

Top Keywords

pulmonary artery
12
artery wall
12
dapagliflozin pulmonary
8
pulmonary vascular
8
vascular remodeling
8
chronic hypoxic
8
hypoxic pulmonary
8
pulmonary arterial
8
chronic hypoxia
8
received saline
8

Similar Publications

VA-ECOM assisted percutaneous mechanical thrombectomy treatment high-risk pulmonary embolism.

Front Cardiovasc Med

December 2024

Department of Vascular Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

Background: Percutaneous mechanical thrombectomy (PMT) is increasingly used in the treatment of intermediate and high-risk acute pulmonary embolism (PE), and the treatment of high-risk PE with the aid of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has also been reported. However, there are few reports of VA-ECOM-assisted PMT in the treatment of high-risk PE. The purpose of this study is to summarize the data of 11 patients with high-risk PE treated with VA-ECMO assisted PMT, and propose feasible treatment methods for such patients.

View Article and Find Full Text PDF

Double outlet right ventricle (DORV) is a rare congenital heart defect where both the aorta and pulmonary artery originate from the right ventricle, often accompanied by additional cardiac anomalies to mitigate circulatory imbalance, though such compensations usually fail. We report a 15-month-old infant with recurrent respiratory infections and poor weight gain, referred for computed tomography angiography. Physical examination showed a small, non-syndromic infant with pallor, tachypnea, irritability, and finger clubbing.

View Article and Find Full Text PDF

Left images: Top: (A) Echocardiography shows a dilated pulmonary artery, large aortopulmonary window (dotted line), and abnormally positioned aortic arch. (B) MIP image reveals superior RV, inferior LV, and elongated arch vessels (arrows). Bottom: MinIP shows a thin left main bronchus and non-aerated RML (asterisk).

View Article and Find Full Text PDF

Associated Cardiac and Extracardiac Anomalies in Patients with Abnormal Coronary Artery from the Pulmonary Artery.

Pediatr Cardiol

January 2025

Department of Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München (DHM), Technische Universität München (TUM), Lazarettstr. 36, 80636, Munich, Germany.

Anomalous origin of coronary arteries from the pulmonary artery (ACAPA) are rare but clinically significant condition with high mortality if left untreated. Even more rarely, ACAPA is associated with other congenital heart defects. From 1974 to 2024, 120 patients with anomalous coronary arteries connected to the pulmonary artery were retrospectively analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!